These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1560 related articles for article (PubMed ID: 23995538)

  • 1. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Sarkozy A; Boussy T; Kourgiannides G; Chierchia GB; Richter S; De Potter T; Geelen P; Wellens F; Spreeuwenberg MD; Brugada P
    Eur Heart J; 2007 Feb; 28(3):334-44. PubMed ID: 17251258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P
    J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S; Uchiyama T; Komatsu Y; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Isobe M; Hirao K; Iesaka Y
    Am J Cardiol; 2013 May; 111(10):1448-51. PubMed ID: 23433764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator.
    Dores H; Reis Santos K; Adragão P; Moscoso Costa F; Galvão Santos P; Carmo P; Cavaco D; Bello Morgado F; Mendes M
    Rev Port Cardiol; 2015 Jun; 34(6):395-402. PubMed ID: 26028488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D; Roberts-Thomson KC; Inada K; Seiler J; Koplan BA; Tedrow UB; Sweeney MO; Epstein LE; Stevenson WG
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.
    Sacher F; Probst V; Iesaka Y; Jacon P; Laborderie J; Mizon-Gérard F; Mabo P; Reuter S; Lamaison D; Takahashi Y; O'Neill MD; Garrigue S; Pierre B; Jaïs P; Pasquié JL; Hocini M; Salvador-Mazenq M; Nogami A; Amiel A; Defaye P; Bordachar P; Boveda S; Maury P; Klug D; Babuty D; Haïssaguerre M; Mansourati J; Clémenty J; Le Marec H
    Circulation; 2006 Nov; 114(22):2317-24. PubMed ID: 17116772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study.
    Holst AG; Jensen HK; Eschen O; Henriksen FL; Kanters J; Bundgaard H; Svendsen JH; Haunsø S; Tfelt-Hansen J
    Europace; 2012 Jul; 14(7):1025-9. PubMed ID: 22286273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current review of Brugada syndrome: from epidemiology to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():12-6. PubMed ID: 20089482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of inappropriate ICD shocks in patients with Brugada syndrome.
    Veltmann C; Kuschyk J; Schimpf R; Streitner F; Schoene N; Borggrefe M; Wolpert C
    Clin Res Cardiol; 2010 Jan; 99(1):37-44. PubMed ID: 19760052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.